Evidence for increased seizure susceptibility in rats exposed to cocaine in utero

Developmental Brain Research

Volumn 102, Issue 2, 1997, Pages 189-196

  Baraban, Scott C ^a,b   McCarthy, Elizabeth B ^b   Schwartzkroin, Philip A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cocaine; Electrophysiology; Epilepsy; Hippocampus; Prenatal; Rat

Indexed keywords

COCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG ABUSE; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; HIPPOCAMPUS; MUSCLE HYPERTONIA; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; COCAINE; DISEASE SUSCEPTIBILITY; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; FEMALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SEIZURES;

EID: 0030796422     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)00096-5     Document Type: Article

References (49)

1. Aghajanian G.K., Rasmussen K. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse. 3:1989;331-338.
2. Anderson-Brown T., Slotkin T.A., Seidler F.J. Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions. Brain Res. 537:1990;197-202.
3. Baraban S.C., Schwartzkroin P.A. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Epilepsy Res. 23:1996;189-194.
4. S.C. Baraban, P.A. Schwartzkroin, Effects of prenatal cocaine exposure on the developing hippocampus: intrinsic and synaptic physiology, J. Neurophysiol. 77 (1997) 126-136.
5. Bingol N., Fuchs M., Diaz V., Stone R.K., Gromisch D.S. Teratogenicity of cocaine in humans. J. Pediatr. 110:1987;93-96.
6. Burchfield D., Abrams R. Cocaine depresses cerebral glucose utilization in fetal sheep. Dev. Brain Res. 73:1993;283-288.
7. Burke M.S., Roth D. Anonymous screening in private obstetric population. Obstet. Gynecol. 81:1993;354-356.
8. Chasnoff I.J. Effects of maternal narcotic vs. nonnarcotic addiction on neonatal neurobehavior and infant development. NIDA Res. Monogr. 59:1985;73-83.
9. Chasnoff I.J., Burns W.J., Schnoll S.H., Burns K.A. Cocaine use during pregnancy. New Engl. J. Med. 313:1985;666-669.
10. Cheruki R., Minkoff H., Feldman J., Parekh A., Glass L. A cohort study of alkaloidal cocaine ('crack') in pregnancy. Obstet. Gynecol. 72:1988;147-151.
11. C.A. Chiriboga, Cocaine and the fetus: methodological issues and neurological correlates, in: R.J. Konkol, G.D. Olsen (Eds.), Prenatal Cocaine Exposure, CRC Press, New York, 1996, pp. 1-21.
12. Church M.W., Dintcheff B.A., Gessner P.K. Dose-dependent consequences of cocaine on pregnancy outcome in the Long-Evans rat. Neurotoxicol. Teratol. 10:1988;51-58.
13. Clow D.W., Hammer R.P. Jr., Kirstein C.L., Spear L.P. Gestational cocaine exposure increases opiate receptor binding in weanling offspring. Dev. Brain Res. 59:1991;179-185.
14. Dixon S.D., Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J. Pediatr. 115:1979;770-780.
15. Doberczak T.M., Shanzer S., Senie R.T., Kandall S.R. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J. Pediatr. 113:1988;354-358.
16. Ellis J.E., Byrd L.D., Sexson W.R., Patterson-Barnett C.A. In utero exposure to cocaine: a review. South. Med. J. 86:1993;725-731.
17. Fantal A.G., MacPhail B.J. The teratogenicity of cocaine. Teratology. 26:1982;17-19.
18. Fantal A.G., Person R.E., Burroughs-Gleim C.J., Mackler B. The direct embryotoxicity of cocaine in rats: effects on mitochondrial activity, cardiac function and growth and development in vitro. Teratology. 42:1990;35-43.
19. Franck J.E., Ginter K.L., Schwartzkroin P.A. Developing genetically epilepsy-prone rats have an abnormal seizure response to flurothyl. Epilepsia. 30:1989;1-6.
20. Frank D.A., Bresnahan K., Zuckerman B.S. Maternal cocaine use: impact on child health and development. Adv. Ped. 40:1993;65-99.
21. Gingras J.L., Muelenaer A., Dalley L.B., O'Donnell K.J. Prenatal cocaine exposure alters postnatal hypoxic arousal responses and hypercarbic ventilatory responses but not pneumocardiograms in prenatally cocaine-exposed term infants. Pediatr. Pulmonol. 18:1994;13-20.
22. Gingras J.L., Weese-Mayer D.E., Humer R.F. Jr., O'Donnell J.O. Cocaine and development: mechanisms of fetal toxicity and neonatal consequences of prenatal cocaine exposure. Early Hum. Dev. 31:1992;1-24.
23. Gressens P., Kosofsky B.E., Evrard P. Cocaine-induced disturbances of corticogenesis in the developing murine brain. Neurosci. Lett. 140:1992;113-116.
24. Hadeed A.J., Siegel S.R. Maternal cocaine use during pregnancy: effects on the newborn infant. Pediatrics. 84:1989;205-210.
25. Kallyanpur S.G., Ryman B.E. Some effects of local anesthetics on cell metabolism. Biochem. Pharmacol. 15:1966;691-701.
26. Kapur R.P., Shaw C.M., Shepard T.H. Brain hemorrhages in cocaine-exposed human fetuses. Teratology. 44:1991;11-18.
27. R.J. Konkol, G. Schuelke, Behavioral and convulsive effects of cocaine metabolites: mechanisms and implications, in: R.J. Konkol, G.D. Olsen (Eds.), Prenatal Cocaine Exposure, CRC Press, New York, 1996, pp. 95-113.
28. Kosofsky B.E., Wilkins A.S., Gressens P., Evrard P. Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities. J. Child Neurol. 9:1994;234-241.
29. Kramer L.D., Locke G.E., Ogunyemi M.D., Nelson L. Neonatal cocaine-related seizures. J. Child Neurol. 5:1990;60-64.
30. Kreisman N.R., Smith M.L. Potassium-induces changes in excitability in the hippocampal CA1 region of immature and adult rats. Dev. Brain Res. 76:1993;67-74.
31. Livesay S., Erlich S., Finnegan L.P. Cocaine and pregnancy: correlation between prenatal care and perinatal outcome. Obstet. Gynecol. 74:1987;883-888.
32. MacGregor S.N., Keith L.G., Chasnoff I.J., Rosner M.A., Chisum G.M., Shaw P., Minogue J.P. Cocaine use during pregnancy: adverse perinatal outcome. Am. J. Obstet. Gynecol. 157:1987;690-696.
33. Mahalik M.P., Gautieri R.F., Mann D.E. Teratogenic potential of cocaine hydrochloride in CF-1 mice. J. Pharmacol. Sci. 69:1980;703-706.
34. Middaugh L.D., Boggan W.O., Bingel S.A., Patrick K.S., Xu W.D. A murine model of prenatal cocaine exposure: effects on the mother and the fetus. Pharmacol. Biochem. Behav. 55:1996;565-574.
35. Moshe S.L., Albala B.J. Nigrostriatal muscimol infusions facilitate the development of seizures in immature rats. Dev. Brain Res. 13:1984;305-308.
36. Nassogne M.-C., Evrard P., Courtoy P.J. Selective neuronal toxicity of cocaine in embryonic mouse brain cocultures. Proc. Natl. Acad. Sci. USA. 92:1995;11029-11033.
37. O'Malley P.M., Johnston L.D., Bachman J.G. Quantitative and qualitative changes in cocaine use among American high school seniors, college students and young adults. NIDA Res. Monogr. 110:1991;19-43.
38. Ostrea E.M., Brady M.J., Gause S., Raymundo A.L., Stevens M. Drug screening of newborns by meconium analysis: a large scale, prospective, epidemiological study. Pediatrics. 89:1992;107-113.
39. Schneider J.W., Chasnoff I.J. Motor assessment of cocaine-exposed infants. Phys. Ther. 68:1988;5-15.
40. Seidler F.J., Slotkin T.A. Fetal cocaine exposure causes persistent noradrenergic hyperactivity in rat brain regions: effects of neurotransmitter turnover and receptors. J. Pharmacol. Exp. Ther. 263:1992;413-421.
41. Singer L., Arendt R., Minnes S. Neurodevelopmental effects of cocaine. Clin. Perinatol. 20:1993;245-262.
42. Snyder-Keller A., Keller R.W. Jr. Prenatal cocaine alters later sensitivity to cocaine-induced seizures. Neurosci. Lett. 191:1995;149-152.
43. Spear L.P., Kirstein C.L., Frambes N.A. Cocaine effects on the developing central nervous system: behavioral, psychopharmacological, and neurochemical studies. Ann. NY Acad. Sci. 562:1989;290-307.
44. Taylor D.C., Falconer M.A. Focal dysplasia of cerebral cortex in epilepsy. J. Neurol. Neurosurg. Psychiatry. 34:1971;369-387.
45. Thadani P.V. Biological mechanisms of perinatal exposure to abused drugs. Synapse. 19:1995;228-232.
46. Traynelis S.F., Dingledine R. Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. J. Neurophysiol. 59:1988;259-276.
47. Tsay C.H., Partridge C., Villarreal S.F., Good W.V., Ferriero D.M. Neurologic and ophthalmologic findings in children exposed to cocaine in utero. J. Child Neurol. 11:1996;25-30.
48. Tyler R., Chugani H., Howard J. A pilot study of cerebral glucose utilization in children with prenatal drug exposure. Ann. Neurol. 34:1993;460A.
49. Vaughn A.J., Carzoli R.P., Sanchez-Ramos L., Murphy S., Khan N., Chiu T. Community wide estimation of illicit drug use in delivering women: prevalence, demographic and associated risk factors. Obstet. Gynecol. 82:1993;92-96.